BACKGROUND: Severe acute respiratory syndrome (SARS) is an emerging infectious
disease, and indeed, the SARS epidemic in Taiwan from March to July 2003 had a great …

Severe acute respiratory syndrome (SARS) is a new disease which has spread rapidly and
widely. We wished to know whether evaluation of in vitro cytokine production could …

This report demonstrates that a rapid decrease of peripheral T cell subsets is a unique
characteristic in patients with SARS during acute infection, although total white blood cell …

Severe acute respiratory syndrome (SARS) has spread to a global pandemic, especially in
Asia. The transmission route of SARS has been clarified, but the immunopathogenesis of …

Background To explore the pathological features and pathogenesis of severe acute
respiratory syndrome (SARS) to provide evidence for the clinical treatment and prevention of …

INTRODUCTION: Severe acute respiratory syndrome (SARS) caused large outbreaks of
atypical pneumonia in 2003, with the largest localized outbreak occurring in Beijing, China …

Although viral replication and overwhelming immune responses are believed to contribute to
the progression of severe acute respiratory syndrome (SARS), little is known about the …

In a cohort of 38 patients with severe acute respiratory syndrome (SARS), we observed
leukopenia in 47% of patients, lymphopenia in 84%, and T lymphopenia in 95%. CD4+ T …

In order to investigate the clinical pathology of severe acute respiratory syndrome (SARS),
the autopsies of three patients who died from SARS in Nan Fang Hospital Guangdong …

Severe acute respiratory syndrome (SARS) has raised a global alert since March 2003. After
its causative agent, SARS-associated coronavirus (SARS-CoV), was confirmed, laboratory …